Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

16.08.2021

1 Ann Oncol
1 BMC Cancer
1 Cancer Lett
2 Cancer Res
1 Clin Cancer Res
1 Gynecol Oncol
1 J Natl Cancer Inst
1 Lancet Oncol
1 Oncogene



    Ann Oncol

  1. MARTIN JE, Khalife-Hachem S, Grinda T, Kfoury M, et al
    Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.
    Ann Oncol. 2021;32:1046-1048.
    >> Share


    BMC Cancer

  2. WANG C, Hu K, Deng L, He W, et al
    Increased risk of breast cancer-specific mortality among cancer survivors who developed breast cancer as a second malignancy.
    BMC Cancer. 2021;21:491.
    >> Share


    Cancer Lett

  3. YOON MJ, Cha H, Ahn J, Lee D, et al
    Dysfunctional activity of classical DNA end-joining renders acquired resistance to carboplatin in human ovarian cancer cells.
    Cancer Lett. 2021;520:267-280.
    >> Share


    Cancer Res

  4. GEETHADEVI A, Nair A, Parashar D, Ku Z, et al
    Oncostatin M Receptor-targeted antibodies suppress STAT3 signaling and inhibit ovarian cancer growth.
    Cancer Res. 2021 Aug 11. pii: 0008-5472.CAN-21-0483.
    >> Share

  5. SHRESTHA R, Llaurado Fernandez M, Dawson A, Hoenisch J, et al
    Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability.
    Cancer Res. 2021 Jan 13. pii: 0008-5472.CAN-20-2222.
    >> Share


    Clin Cancer Res

  6. SZTUPINSZKI Z, Diossy M, Borcsok J, Prosz A, et al
    Comparative Assessment of Diagnostic Homologous Recombination Deficiency associated mutational signatures in ovarian cancer.
    Clin Cancer Res. 2021 Aug 11. pii: 1078-0432.CCR-21-0981.
    >> Share


    Gynecol Oncol

  7. WENTZENSEN N, O'Brien KM
    Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
    Gynecol Oncol. 2021 Aug 5. pii: S0090-8258(21)00598.
    >> Share


    J Natl Cancer Inst

  8. KURIAN AW, Abrahamse P, Bondarenko I, Hamilton AS, et al
    Association of Genetic Testing Results with Mortality Among Women with Breast Cancer or Ovarian Cancer.
    J Natl Cancer Inst. 2021 Aug 9. pii: 6346986. doi: 10.1093.
    >> Share


    Lancet Oncol

  9. MONK BJ, Colombo N, Oza AM, Fujiwara K, et al
    Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
    Lancet Oncol. 2021 Aug 4. pii: S1470-2045(21)00342.
    >> Share


    Oncogene

  10. LI H, Qi Z, Niu Y, Yang Y, et al
    FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer.
    Oncogene. 2021 Aug 6. pii: 10.1038/s41388-021-01957.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016